-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Inflammation is considered a key factor
Routine diagnostic methods include blood biomarker testing, tissue biopsy, and urinalysis, but these are usually single-point tests and cannot be used for real-time, dynamic monitoring
Some recent studies have shown that RNA can regulate the occurrence, development, and regression of inflammation by changing expression and localization, and is a key regulator of the inflammatory process, so RNA may serve as a biomarker for inflammation diagnosis, but in vivo optical imaging using RNA as a biomarker for inflammation has not been demonstrated
On September 1, 2022, the Li Lele Research Group of the National Center for Nanoscience published a paper in the journal Nature Biomedical Engineering titled Spatially resolved in vivo imaging of inflammation-associated mRNA via enzymatic fluorescence amplification in a Molecular Beacon's research paper
The study designed and constructed an inflammatory cell-specific signal amplification method based on enzyme-triggered molecular beacons, which achieved real-time dynamic imaging and early diagnosis of inflammation by spatially selectively amplifying inflammation-related RNA imaging signals
Over the past two decades, scientists have developed a range of techniques that can sensitively detect RNA, including fluorescence in situ hybridization (FISH), in situ sequencing, and other methods that can provide RNA detection
However, amplification of RNA signals is required when performing RNA imaging, but these methods often require early fixation and permeation of cells
Molecular Beacon (MB) provides a straightforward and widely applicable tool for RNA analysis, and MB-assisted signal amplification can improve RNA detection sensitivity, but it is only suitable for detection in test tubes and has not yet been applied to RNA imaging
In March 2019, Li Lele's research group published a paper in JACS, which realized spatiotemporal controllable live-cell RNA imaging by constructing photosensitive molecular beacons and combining with conversion luminescence
However, in this method, a molecular beacon can only recognize one target RNA, so the signal output is insufficient and the detection sensitivity is not high
In this latest study, Li Lele's team designed and developed a molecular beacon (MB) probe triggered by human deminine/despyrimidine endonuclease 1 (APE1) - E-MBP, based on previous research, for specifically magnifying RNA in vivo, so that inflammation can be directly assessed
APE1 is a versatile enzyme that repairs DNA damage by removing the depurine/depyrimidine site, and the signal amplification mechanism of this method is the selective cleavage of APE1 target RNA-dependent inflammatory cells to molecular beacons, which can specifically multiply the response signal within inflammatory cells, enabling high-letter-back ratio imaging
Enzymatic signal amplification enables instem-resolved imaging of inflammation-related mRNAs
Next, the team selected the mRNA of the important inflammatory biomarker IL-6 as a target to verify the sensitivity and tissue specificity of E-MBP in living animals, delivering E-MBP into cells through polymer nanocarriers
Overall, this study provides a new approach to highly sensitive imaging of inflammation-related RNA that is expected to be applied to the early diagnosis and real-time evaluation of the treatment process of inflammation-related diseases
Sheng Chuangui and Associate Researcher Zhao Jian of the National Nanoscience Center are the co-first authors of the article, Li Lele, a researcher at the National Nanoscience Center, is the corresponding author, and Professor Huang Yuanyu of Beijing Institute of Technology and Academician Zhao Yuliang of the National Center for Nanoscience provide strong support
Original source:
Sheng, C.